chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider(s) recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 16-JUN-2010, a healthcare provider, at a pharmacy, administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 18-DEC-2016, the patient was treated by a physician/MD for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 71-year-old male patient who received SHINGRIX for prophylaxis. On 30th July 2018 16:00, the patient received the 2nd dose of SHINGRIX (intramuscular). In July 2018, less than a day after receiving SHINGRIX, the patient experienced muscle pain, lethargy, depression and influenza-like symptoms. On an unknown date, the outcome of the muscle pain, lethargy, depression and influenza-like symptoms were unchanged. It was unknown if the reporter considered the muscle pain, lethargy, depression and influenza-like symptoms to be related to SHINGRIX. Additional information was received as follows: The patient received SHINGRIX on the left arm. In morning of the reporting day, the patient experienced muscle aches all over the body, flu like symptoms, lethargy and depression. The patient had an appointment with his cardiologist in two to three weeks from the reporting date. The patient gave permission to contact his physician. No further details were provided by the patient. The patient was referred to his health care provider.
Information has been received from a physician concerning a 15 year old female patient with no pertinent medical history, drug reactions or allergies who on 19-JAN-2010, was vaccinated with a first dose of GARDASIL (lot number not reported), on 08-APR-2010 was vaccinated with a second dose of GARDASIL (lot number not reported) and on 17-NOV-2011 was vaccinated intramuscularly with a 0.5 ml third dose of GARDASIL (669795/1317AA, expiration date 13-OCT-2013). There was no concomitant medication. The physician reported that on 17-NOV-2011 the patient felt well after receiving the third dose until late in the evening 8 hours after vaccine administration the patient experienced syncope, dizziness, weakness, shakiness and chest pain. The patient was seen in the office the following day (on 18-NOV-2011) her blood pressure was 138/80 and was sweaty. The patient was sent to the emergency room where work up (blood tests, Chest X-Ray (CxR), Electrocardiogram (EKG)) were performed and all normal, urine drug screen was also performed (results not provided). The patient continued to feel tired dizzy and had a noticeable tremor of the right hand (BP 120/80). The physician inquired about recommendations regarding treatment for syncope, dizziness, weakness, shakiness and chest pain related to the third dose of GARDASIL given to the patient. At the time of the report the patient's events persisted. No treatment was given for the events. A neurology consult was being request. Syncope, dizziness, shakiness, weakness and chest pain were considered to be disabling by the physician. Additional information has been requested.
The day of vaccine pt developed headache & soreness at site. Two days after vaccine he started to lose sight in right eye. Four days after vaccine he had nearly complete loss of vision in right eye and severe headache. Diagnosed with optic neuritis.
Swelling on injection leg to double size of other leg. Poor sleep for 4 days, developed upper respiratory symptoms within 24 hours that have lasted a week.
day after the first Pfizer vaccination (18 hours)  Pt is a 16 year old female with history of anaphylaxis and asthma who presents today with allergic reaction after receiving her Pfizer vaccine.  Patient states she had her first dose yesterday, but did not have any immediate reaction.  This morning when she was running at school she began to notice itching to her face and scalp as well as swelling to her nose and difficulty breathing.  Mother gave her EpiPen and Benadryl with significant improvement in her symptoms.  No report of nausea or vomiting.  No report of abdominal pain.  She denies any new foods or shampoos or perfumes.  Mom does report concerned that she has a history of rebound anaphylaxis generally 6 hours after the initial insult.
Inflammation, redness, and itchiness at injection site.  About 3inch in diameter.  Still suffering on second day of rash.
I started having irregular heartbeat and then I went to ER and they said I had premature heartbeat and it went on for a while but the doctors said it might be because of the vaccination they did not give me any medicines. All of my blood work came back normal but i had a really bad headache and high blood pressure.
Client had reported he had not had any COVID vaccine and requested the Novavax. It was later determined he had already had a Pfizer primary series. Client was notified that he did not need to return for the second dose. Client wants to get the second dose of Novavax and has contacted his primary care provider and will come in with a prescription for the second dose.
I was diagnosed with Covid on 12/10/2022 with an at home test, I called my doctor, and they sent me to urgent care and they were able to prescribe PAXLOVID. I felt better for 10 days and then I started to feel the symptoms all over again. I would sleep for roughly 16 hours a week, could barely move daily, a severe cough that lasted two months, I still experience body aches and all my joints hurt. I just overall feel beat up. After two weeks I caught the flu.
This Pt was permitted to create an acct, make an appt prior to this clinic date and get the vaccine before the  system stopped due to the age. It was not caught until check out when Pt 2nd shot appt was being made. They showed up on the list of people WITH scheduled appts in and were NOT added at the time of the clinic.
within 24 hours after second dose of vaccine my mother complained of chest pains and shortness of breath.  She saw her Primary Care Dr on  5/10/2021 after experiencing dizziness, fatigue, confusion.  She had lost a considerable amount of weight during this time and I was concerned and accompanied her to the doctor visit.  Dr prescribed cyanocobalamin B-12 as she had been defficient in her latest blood analysis on 3/15/2021.  She also added Donepezil 5mg tablet daily and trazodone 50 mg nightly to help with sleep.  She gave referral to get Neuroligical evaluation.  My mother had a driving episode on 4/30/2021 where she was taken to Medical Center and some Scans were taken of her brain that were apparently normal they contacted me to pick her up around 2:30 AM 5/01/2021.  The number on her release folder to obtain medical Records.  My mother was residing with me my home until her appointment for evaluation .  She passed away on 6/02/2021 in my home.. Dr  was contacted to sign off on her Death Certificate .  I have not received Death Certificate as of today but I believe the cause she was putting was Natural Causes due to age.
76 year old Hispanic female experiencing  sore left arm (muscle pain) on left arm when the first dose of the covid vaccine was given to her on 6/10/2021 to the present (12/9/2021). Got her second covid vaccine on 6/30/2021 and still was experiencing  sore left arm (muscle pain) . She can't sleep on her left side or bend her arm to the back and say's that there is a hard lump in that area where the vaccine was given that developed when she got the vaccine. She reported to her health care provider Dr.  The symptom of the sore left arm muscle pain is still ongoing and has gotten worse.
A pharmacist reported a few patients and  staff members received vax, post vax symptoms consisting of aches and pains, diarrhea, and malaise. With in 3-5 days, all patients recovered. The reporter was unable to specify the number of patients who experienced these events, or to identify any of the pt.
Information has been received from a health professional concerning a 17 year old female who on 27-FEB-2007 was vaccinated with a second dose of Gardasil.  On 27-FEB-2007 the patient "felt shaky", developed a headache, a stomach ache and felt warm.  On 02-JUL-2007 at 11:15 the patient was vaccinated IM with a third dose of Gardasil (lot # 656825/0307U).  Subsequently at 5:00 pm she "felt shaky", had a headache, a stomach ache and felt warm.  She "felt better after 2 days."  Additional information has been requested.
Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program Pfizer First Connect. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the ninth of 20 reports.  A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown.    Information on the lot/batch number has been requested.; Sender's Comments: Based on the information provided, the lack of efficacy cannot be excluded for vaccine BNT162B2. ,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient
Patient was asked screening questions and asked birthdate.  Patient stated that he was 18 years of age.  His birthdate indicates that he is only 17 and this was caught after the vaccination was already given.
Pfizer covid vaccine was stored outside of manufacturer's recommendation. Specifically, the vaccine was frozen longer than recommended. Patient was re-vaccinated on 11/30/2021 due to Pfizer recommendations.
Did the adverse event start after the first or second vaccination?  only one dose (after the shot 5min after his arm completely went numb) when waiting at the site for 15min he experienced nausea and dizziness  Recommendation:  Please make sure he drinks lots of fluids he could take Pedialyte and if symptoms worsen please contact doctor and go the nearest ER. Mother would like a follow up call tomorrow at 10:00am I told her we would try to call her back at that time if its not busy, if not expect a call later in the afternoon.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 14-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported No treatment medication were reported. The vaccine was administered after 4 days from  time from first puncture.   This case was linked to MOD-2021-332638 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up received contains no new information , but initial version the vaccine was administered after 4 days from  time from first puncture was missed and added in inarrative
Had a shingles outbreak about a week ago.; And having big escalation equlibrium issues since about a week post 2nd dose.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 15Mar2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and well controlled seizures. The patient had iodine contrast media (reported as iodine based contrast) allergy and contrast media (reported as computed tomography scan contrast dye) allergy. The patient previously took intravenous lidocaine (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy in the form of severe bad central nervous system reaction. Concomitant medications taken within two weeks of vaccination included lamotrigine (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL), both from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 22Feb2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient had a shingles outbreak about a week ago before the time of report. The patient was having big escalation equlibrium issues since about a week post second dose on 02Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events shingles outbreak about a week ago, having big escalation equlibrium issues since about a week post second dose was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Had both shots 6/1/06 came into office next day legs felt like jello, hard to walk, low grade fever (100.4) felt stiff all over, was hospitalized had trouble moving legs. C/o pain, weakness, achy was given IV fluids, IV antibiotics within 4 hrs was much improved, was rechecked on 6/5/06 no other problems.
On 10/25/00, pt returned with a 50 cent piece-sized reddened area on left upper arm, warm to the touch, a knot palpable and pt complaining of entire left arm pain. Pt was instructed to use ice and take ibuprofen. On 10/31/00, pt's arm is completely better.
Now the muscle in her arm still hurts when she rotates it 360 degrees; This is a spontaneous report from a contactable consumer. A 41-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection; Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm on 31Mar2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 11Mar2021 for covid-19 immunisation. On an unspecified date caller states she had to request her second dose be in her opposite arm of the first dose because it was still sore from the first dose, and now the muscle in her arm still hurts when she rotates it 360 degrees. Caller states it also hurts when she extends her arm backwards. Caller asks if other people have had this or should she go see a doctor. Caller also asks which HCP she should go to. Caller states so it looks to me that either I go to my doctor and pay my own bills or I hire a lawyer and have you guys pay for it. So, Pfizer is basically offering no follow up for patients in terms of maybe looking themselves and assessing my arm them-selves, nothing. You, Pfizer will not have your doctors look at my arm. So, this legal department could reimburse me for my expenditure. So, the possibility of going to an office owned by Pfizer where there are doctors working with Pfizer checking my arm out themselves, by Pfizer isn't an option. Either I go to my doctor and submit a claim for reimbursement or that's it. Pfizer will not check my arm and they do not have doctors to see my arm or evaluate my arm or suggest any course of action as a result of taking the vaccine in that arm is that correct? I do want to share that this conversation is also recorded on my end on my side, and I will be taking this further thank you so much. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Numbness that started between about 1/10/2021 and 1/15/2021.  It started in the great toe of one foot and then within about 1 week was noticeable in the great toe of the other foot.  Then within 1 month, it was noticeable in the fingers of both hands as well.  It seems to have improved somewhat , but still is noticeable.   There have been some tingling sensations, but primarily there has been numbness.
Sore throat, first just like a cough but it got progressive. I was running a low grade fever for a while and fatigue that would come and go. The test stayed positive for 2 weeks.
Nausea, diarrhea, rib cage pain so bad I couldn't lie down/sleep, exhaustion, Muscle aches and pain, loss of appetite, cough,
Reports raised warm area left deltoid injection site, fever, chills, nausea and vomiting.
Received Pfizer vaccine on 4/5/21, 4/26/21 and 10/28/21. COVID positive 1/18/22. On admission on 1/18/22: Found COVID-19 positive.  Saturation 89% requiring NC oxygen. Acute hypoxia requiring N/C oxygen- likely from COPD exacerbation, less likely from covid.  Wheezing improved with steroid and inhaler. Suspected right lower lobe pneumonia. On antibiotic. Short of breath improved.  Oxygen requirement improved, 6 minute walk test done.  No oxygen recommended at rest or with exertion. Patient is medically stable to be discharged on  1/21/22.   Recently diagnosed with COVID on January 18th presents to the ER with complaints of shortness of breath.  Patient was admitted here on the 18th for a few days for COVID in COPD exacerbation.  Patient states he did not feel he was ready to be discharged that time however patient was doing well on the day of his discharge. Pt condition gradually improved. He had high WBC yesterday but that is improving. High WBC likely due to steroids. Discharged on 1/28/22.
Mom states 24 hours post vaccination pt had 2 pox on nose. found patch of 10 red raised bumps on left shoulder et 1 in middle of back, Pt picked pox on nose, leaving sm craters. Other areas on back never came to a head and faded. No other complications.
?After first booster on 11/19/2021, I began to notice 1 small, reddish area on my right lower leg, resembling a skin rash about the size of a quarter. In a short time, 2 more appeared on same leg and 1 appeared on left inside thigh. I applied antibiotic cream, CBD cream, kept it clean and they gradually faded away.?
This spontaneous report as received from a registered nurse refers to a female patient (other nurse) of unknown age. The registered nurse stated that during administration of a dose of PNEUMOVAX 23 to an unspecified patient on 10-AUG-2015, some of the PNEUMOVAX 23 lot#L003227, expiration date 13-OCT-2016, inadvertently splashed in the eye of the nurse who was administering the dose and caused a burning sensation in the nurse's eye. The primary reporter confirmed that despite this occurrence, the unspecified patient was not topically exposed to the vaccine and received the full dose of PNEUMOVAX 23. No adverse effect was reported for the unspecified patient. Causality assessment was not provided. Additional information has been requested.
pt recvd vax & devel inj site rxn of redness,warmth,itching & swelling of area 4 inches diam. Still itching when seen by MD 05/05/97. Tx w/pred. Is 1 of 2 pt this site w/adverse exp p/vax w/different lots of tetanus & diphtheria toxoids.